FDA Orange Book
Is there a generic for Spritam?
Spritam contains levetiracetam. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Spritam (levetiracetam). The Orange Book shows its last listed patent expires March 14, 2034.
Run it in Rivvi
Map Spritam and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Spritam products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, for suspension, oral | 1GM | Discontinued | None | 0 | None |
| tablet, for suspension, oral | 250MG | Marketed (Rx) | None | 0 | None |
| tablet, for suspension, oral | 500MG | Marketed (Rx) | None | 0 | None |
| tablet, for suspension, oral | 750MG | Discontinued | None | 0 | None |
NDA 207958, held by APRECIA PHARMACEUTICALS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Spritam patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9339489 | March 14, 2034 | Drug product | U-1850 | 207958 |
| 9669009 | March 14, 2034 | Method of use | U-1850 | 207958 |
| 9669009 | March 14, 2034 | Method of use | U-2021 | 207958 |
| 9669009 | March 14, 2034 | Method of use | U-2022 | 207958 |
| 11160786 | March 14, 2034 | Drug product | None | 207958 |
Spritam NDC codes
Questions
Is there a generic for Spritam?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Spritam (levetiracetam). The Orange Book shows its last listed patent expires March 14, 2034.
What is the generic name for Spritam?
The active ingredient in Spritam is levetiracetam, per the FDA Orange Book.
When does the Spritam patent expire?
The last patent listed for Spritam in the Orange Book expires March 14, 2034. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.